Clinical effects of probiotic bifidobacterium longum BB536 on immune function and intestinal microbiota in elderly patients receiving enteral tube feeding

Journal of Parenteral and Enteral Nutrition

Volumn 37, Issue 5, 2013, Pages 631-640

  Akatsu, Hiroyasu ^a,b   Iwabuchi, Noriyuki ^c   Xiao, Jin Zhong ^c   Matsuyama, Zenjiro ^a   Kurihara, Rina ^a   Okuda, Kenji ^a   Yamamoto, Takayuki ^a   Maruyama, Mitsuo ^b  

^a NAGOYA CITY UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^c MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Bifidobacterium longum BB536; elderly; immune function; natural killer cell activity; probiotics; vaccine

Indexed keywords

IMMUNOGLOBULIN A; INFLUENZA VACCINE; PLACEBO; PROBIOTIC AGENT;

ABSENCE OF SIDE EFFECTS; AGED; ANTIBODY TITER; ARTICLE; BACTERIAL CELL; BIFIDOBACTERIUM LONGUM; BODY TEMPERATURE; CELL ACTIVITY; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENTERIC FEEDING; FECES MICROFLORA; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INTESTINE FLORA; INTESTINE MOTILITY; MALE; NATURAL KILLER CELL; POWDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION;

BIFIDOBACTERIUM LONGUM BB536; ELDERLY; IMMUNE FUNCTION; NATURAL KILLER CELL ACTIVITY; PROBIOTICS; VACCINE;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; BIFIDOBACTERIUM; BIOLOGICAL MARKERS; BODY MASS INDEX; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FECES; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNE SYSTEM; IMMUNOGLOBULIN A; INFLUENZA VACCINES; INTESTINES; KILLER CELLS, NATURAL; MALE; MICROBIOTA; NUTRITIONAL STATUS; PROBIOTICS; VACCINATION;

EID: 84883528836     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607112467819     Document Type: Article

References (47)

1. Aging Society White Paper. Tokyo, Japan: Cabinet Office ; 2011 :
2. Norman DC. Fever in the elderly. Clin Infect Dis. 2000 ; 31: 148-151
3. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults?. Curr Opin Immunol. 2009 ; 21: 418-424
4. Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010 ; 104: 183-190
5. Lesourd B. Nutritional factors and immunological ageing. Proc Nutr Soc. 2006 ; 65: 319-325
6. Sullivan DH, Sun S, Walls RC. Protein-energy undernutrition among elderly hospitalized patients: a prospective study. JAMA. 1999 ; 281: 2013-2019
7. Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?. BMJ. 1999 ; 318: 999-1003
8. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001 ; 48: 198-205
9. Mueller S, Saunier K, Hanisch C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006 ; 72: 1027-1033
10. Blum S, Schiffrin EJ. Intestinal microflora and homeostasis of the mucosal immune response: implications for probiotic bacteria?. Curr Issues Intest Microbiol. 2003 ; 4: 53-60
11. Guidelines for the Evaluation of Probiotics in Food. London, Canada: World Health Organization ; 2002 :
12. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009 ; 124: e172 - e179
13. de Vrese M, Winkler P, Rautenberg P, et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr. 2005 ; 24: 481-491
14. Olivares M, Díaz-Ropero MP, Sierra S, et al. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition. 2007 ; 23: 254-260
15. Takeda K, Okumura K. Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr. 2007 ; 137 (3). 791S - 793S
16. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001 ; 74: 833-839
17. Kabeerdoss J, Devi RS, Mary RR, et al. Effect of yoghurt containing Bifidobacterium lactis Bb12(R) on faecal excretion of secretory immunoglobulin A and human beta-defensin-2 in healthy adult volunteers. Nutr J. 2011 ; 10: 138
18. Kotani Y, Shinkai S, Okamatsu H, et al. Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing. 2010 ; 7: 11
19. Namba K, Hatano M, Yaeshima T, Takase M, Suzuki K. Effects of Bifidobacterium longum BB536 administration on influenza infection, influenza vaccine antibody titer, and cell-mediated immunity in the elderly. Biosci Biotechnol Biochem. 2010 ; 74: 939-945
20. Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br J Nutr. 2012 ; 107: 876-884
21. Xiao JZ Handbook of Probiotics and Prebiotics. 536. In: LeeKLSalminenS, eds. Handbook of Probiotics and Prebiotics. 2nd ed.New York: John Wiley; 2009:488-491. Lee KL Salminen S, ed. New York: John Wiley ; 488-491.
22. Iwabuchi N, Xiao JZ, Yaeshima T, Iwatsuki K. Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice. Biol Pharm Bull. 2011 ; 34: 1352-1355
23. Matsumoto T, Ishikawa H, Tateda K, Yaeshima T, Ishibashi N, Yamaguchi K. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice. J Appl Microbiol. 2008 ; 104: 672-680
24. Xiao JZ, Kondo S, Yanagisawa N, et al. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int. 2007 ; 56: 67-75
25. Xiao JZ, Kondo S, Yanagisawa N, et al. Probiotics in the treatment of Japanese cedar pollinosis: a double-blind placebo-controlled trial. Clin Exp Allergy. 2006 ; 36: 1425-1435
26. O'Donnell LJ, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ. 1990 ; 300: 439-440
27. Odamaki T, Xiao JZ, Iwabuchi N, et al. Fluctuation of fecal microbiota in individuals with Japanese cedar pollinosis during the pollen season and influence of probiotic intake. J Investig Allergol Clin Immunol. 2007 ; 17: 92-100
28. Matsuki T, Watanabe K, Fujimoto J, et al. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol. 2004 ; 70: 167-173
29. Namba K, Hatano M, Yaeshima T, Ishibashi N, Tamura T. Method of detecting Bifidobacterium infantis.. 2005 ;:
30. Gianotti L, Morelli L, Galbiati F, et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol. 2010 ; 16: 167-175
31. Bharucha AE. Constipation. Best Pract Res Clin Gastroenterol. 2007 ; 21: 709-731
32. Mitsuoka T, Kaneuchi C. Ecology in the bifidobacteria. Am J Clin Nutr. 1977 ; 30: 1799-1810
33. Benno Y, Endo K, Mizutani T, Namba Y, Komori T, Mitsuoka T. Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl Environ Microbiol. 1989 ; 55: 1100-1105
34. Yaeshima T, Takahashi S, Matsumoto N, Ishibashi N, Hayasawa H, Iino H. Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: a comparison with standard yogurt. Biosci Microflora. 1997 ; 16: 73-77
35. Ogata T, Nakamura T, Yaeshima T, et al. Effect of Bifidobacterium longum BB536 administration on the intestinal environment, defecation frequency and fecal characteristics of human volunteers. Biosci Microflora. 1997 ; 16: 53-58
36. Hoffman-Goetz L, Pedersen BK. Exercise and the immune system: a model of the stress response?. Immunol Today. 1994 ; 15: 382-387
37. Nakachi K, Imai K. Environmental and physiological influences on human natural killer cell activity in relation to good health practices. Jpn J Cancer Res. 1992 ; 83: 798-805
38. Macpherson AJ, McCoy KD, Johansen FE, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol. 2008 ; 1: 11-22
39. Takahashi T, Nakagawa E, Nara T, Yajima T, Kuwata T. Effects of orally ingested Bifidobacterium longum on the mucosal IgA response of mice to dietary antigens. Biosci Biotechnol Biochem. 1998 ; 62: 10-15
40. Tejada-Simon MV, Lee JH, Ustunol Z, Pestka JJ. Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci. 1999 ; 82: 649-660
41. Chen WH, Kozlovsky BF, Effros RB, Grubeck-Loebenstein B, Edelman R, Sztein MB. Vaccination in the elderly: an immunological perspective. Trends Immunol. 2009 ; 30: 351-359
42. Boge T, Rémigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine. 2009 ; 27: 5677-5684
43. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr. 2005 ; 44: 406-413
44. French PW, Penny R. Use of probiotic bacteria as an adjuvant for an influenza vaccine. Int J Prebiotics Probiotics. 2009 ; 4: 175-180
45. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med. 2010 ; 16: 228-231
46. Ichinohe T, Pang IK, Kumamoto Y, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc Natl Acad Sci U S A. 2011 ; 108: 5354-5359
47. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med. 2009 ; 206: 79-87